Guardant Health
GH
#985
Rank
A$34.21 B
Marketcap
A$254.95
Share price
-3.51%
Change (1 day)
68.64%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total assets

Total assets on the balance sheet as of June 2026 : A$2.72 Billion

According to Guardant Health 's latest financial reports the company's total assets are A$2.72 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Guardant Health - Total assets on balance sheet (from 2017 to 2026)

Total assets by year

Year Total assets Change
2025-12-31A$3.00 B25.87%
2024-12-31A$2.38 B-8.91%
2023-12-31A$2.62 B10.83%
2022-12-31A$2.36 B-22.19%
2021-12-31A$3.04 B2.92%
2020-12-31A$2.95 B114.91%
2019-12-31A$1.37 B64.88%
2018-12-31A$0.83 B89.82%
2017-12-31A$0.43 B171.64%
2016-12-31A$0.16 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Neogen
NEOG
A$4.77 B 74.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
A$3.78 B 38.97%๐Ÿ‡บ๐Ÿ‡ธ USA